Macrophages, Immunity, and Metabolic Disease

Immunity

Volumn 41, Issue 1, 2014, Pages 36-48

  McNelis, JoanneC ^a   Olefsky, JerroldM ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ANIMALS; CYTOKINES; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIVER; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MUSCLE, SKELETAL; OBESITY; SIGNAL TRANSDUCTION;

EID: 84904392112     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.05.010     Document Type: Review

References (127)

1. Ahmadian M., Suh J.M., Hah N., Liddle C., Atkins A.R., Downes M., Evans R.M. PPARγ signaling and metabolism: the good, the bad and the future. Nat. Med. 2013, 19:557-566.
2. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.-W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 2005, 11:191-198.
3. Bandyopadhyay G.K., Yu J.G., Ofrecio J., Olefsky J.M. Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 2005, 54:2351-2359.
4. Bellingan G.J., Caldwell H., Howie S.E., Dransfield I., Haslett C. Invivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J.Immunol. 1996, 157:2577-2585.
5. Bernstein L.E., Berry J., Kim S., Canavan B., Grinspoon S.K. Effects of etanercept in patients with the metabolic syndrome. Arch. Intern. Med. 2006, 166:902-908.
6. Biswas S.K., Mantovani A. Orchestration of metabolism by macrophages. Cell Metab. 2012, 15:432-437.
7. Bruun J.M., Helge J.W., Richelsen B., Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E961-E967.
8. Bu L., Gao M., Qu S., Liu D. Intraperitoneal injection of clodronate liposomes eliminates visceral adipose macrophages and blocks high-fat diet-induced weight gain and development of insulin resistance. AAPS J. 2013, 15:1001-1011.
9. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 2005, 11:183-190.
10. National Diabetes FactSheet: National Estimates and General Information on Diabetes and Prediabetes in the United States 2011, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta.
11. Chen C.Y., Gherzi R., Andersen J.S., Gaietta G., Jürchott K., Royer H.D., Mann M., Karin M. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev. 2000, 14:1236-1248.
12. Chen A., Mumick S., Zhang C., Lamb J., Dai H., Weingarth D., Mudgett J., Chen H., MacNeil D.J., Reitman M.L., Qian S. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes. Res. 2005, 13:1311-1320.
13. Chen Q., Wang H., Liu Y., Song Y., Lai L., Han Q., Cao X., Wang Q. Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1β production in macrophages by targeting STAT3. PLoS ONE 2012, 7:e42971.
14. Christiansen T., Richelsen B., Bruun J.M. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int. J. Obes. (Lond.) 2005, 29:146-150.
15. Cipolletta D., Feuerer M., Li A., Kamei N., Lee J., Shoelson S.E., Benoist C., Mathis D. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012, 486:549-553.
16. Cramer T., Yamanishi Y., Clausen B.E., Förster I., Pawlinski R., Mackman N., Haase V.H., Jaenisch R., Corr M., Nizet V., et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003, 112:645-657.
17. DeFuria J., Belkina A.C., Jagannathan-Bogdan M., Snyder-Cappione J., Carr J.D., Nersesova Y.R., Markham D., Strissel K.J., Watkins A.A., Zhu M., et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc. Natl. Acad. Sci. USA 2013, 110:5133-5138.
18. Deng T., Lyon C.J., Minze L.J., Lin J., Zou J., Liu J.Z., Ren Y., Yin Z., Hamilton D.J., Reardon P.R., et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab. 2013, 17:411-422.
19. Desvergne B. PPARdelta/beta: the lobbyist switching macrophage allegiance in favor of metabolism. Cell Metab. 2008, 7:467-469.
20. Dominguez H., Storgaard H., Rask-Madsen C., Steffen Hermann T., Ihlemann N., Baunbjerg Nielsen D., Spohr C., Kober L., Vaag A., Torp-Pedersen C. Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes. J.Vasc. Res. 2005, 42:517-525.
21. Eller K., Kirsch A., Wolf A.M., Sopper S., Tagwerker A., Stanzl U., Wolf D., Patsch W., Rosenkranz A.R., Eller P. Potential role of regulatory Tcells in reversing obesity-linked insulin resistance and diabetic nephropathy. Diabetes 2011, 60:2954-2962.
22. Emanuelli B., Peraldi P., Filloux C., Sawka-Verhelle D., Hilton D., Van Obberghen E. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J.Biol. Chem. 2000, 275:15985-15991.
23. Feig J.E., Shang Y., Rotllan N., Vengrenyuk Y., Wu C., Shamir R., Torra I.P., Fernandez-Hernando C., Fisher E.A., Garabedian M.J. Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages. PLoS ONE 2011, 6:e28534.
24. Feingold K.R., Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992, 41(Suppl 2):97-101.
25. Feng B., Jiao P., Nie Y., Kim T., Jun D., van Rooijen N., Yang Z., Xu H. Clodronate liposomes improve metabolic profile and reduce visceral adipose macrophage content in diet-induced obese mice. PLoS ONE 2011, 6:e24358.
26. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., Lee J., Goldfine A.B., Benoist C., Shoelson S., Mathis D. Lean, but not obese, fat is enriched for a unique population of regulatory Tcells that affect metabolic parameters. Nat. Med. 2009, 15:930-939.
27. Fink L.N., Oberbach A., Costford S.R., Chan K.L., Sams A., Blüher M., Klip A. Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes. Diabetologia 2013, 56:1623-1628.
28. Fink L.N., Costford S.R., Lee Y.S., Jensen T.E., Bilan P.J., Oberbach A., Blüher M., Olefsky J.M., Sams A., Klip A. Pro-Inflammatory macrophages increase in skeletal muscle of high fat-Fed mice and correlate with metabolic risk markers in humans. Obesity (Silver Spring) 2014, 22:747-757.
29. Funk S.D., Orr A.W. Ephs and ephrins resurface in inflammation, immunity, and atherosclerosis. Pharmacol. Res. 2013, 67:42-52.
30. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J.Clin. Invest. 2004, 114:1752-1761.
31. Gao Z., Hwang D., Bataille F., Lefevre M., York D., Quon M.J., Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J.Biol. Chem. 2002, 277:48115-48121.
32. Gao Z., Zuberi A., Quon M.J., Dong Z., Ye J. Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J.Biol. Chem. 2003, 278:24944-24950.
33. Goh Y.P.S., Henderson N.C., Heredia J.E., Red Eagle A., Odegaard J.I., Lehwald N., Nguyen K.D., Sheppard D., Mukundan L., Locksley R.M., Chawla A. Eosinophils secrete IL-4 to facilitate liver regeneration. Proc. Natl. Acad. Sci. USA 2013, 110:9914-9919.
34. Goldfine A.B., Buck J.S., Desouza C., Fonseca V., Chen Y.-D.I., Shoelson S.E., Jablonski K.A., Creager M.A. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes Care 2013, 36:4132-4139. TINSAL-FMD (Targeting Inflammation Using Salsalate in Type 2 Diabetes-Flow-Mediated Dilation) Ancillary Study Team.
35. Gutierrez D.A., Kennedy A., Orr J.S., Anderson E.K., Webb C.D., Gerrald W.K., Hasty A.H. Aberrant accumulation of undifferentiated myeloid cells in the adipose tissue of CCR2-deficient mice delays improvements in insulin sensitivity. Diabetes 2011, 60:2820-2829.
36. Hamaguchi M., Sakaguchi S. Regulatory Tcells expressing PPAR-γ control inflammation in obesity. Cell Metab. 2012, 16:4-6.
37. Hams E., Locksley R.M., McKenzie A.N.J., Fallon P.G. Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J.Immunol. 2013, 191:5349-5353.
38. Han M.S., Jung D.Y., Morel C., Lakhani S.A., Kim J.K., Flavell R.A., Davis R.J. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 2013, 339:218-222.
39. Haneklaus M., Gerlic M., O'Neill L.A.J., Masters S.L. miR-223: infection, inflammation and cancer. J.Intern. Med. 2013, 274:215-226.
40. Hevener A.L., Olefsky J.M., Reichart D., Nguyen M.T.A., Bandyopadyhay G., Leung H.-Y., Watt M.J., Benner C., Febbraio M.A., Nguyen A.-K., et al. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J.Clin. Invest. 2007, 117:1658-1669.
41. Holland W.L., Bikman B.T., Wang L.-P., Yuguang G., Sargent K.M., Bulchand S., Knotts T.A., Shui G., Clegg D.J., Wenk M.R., et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J.Clin. Invest. 2011, 121:1858-1870.
42. Horrillo R., González-Périz A., Martínez-Clemente M., López-Parra M., Ferré N., Titos E., Morán-Salvador E., Deulofeu R., Arroyo V., Clària J. 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity. J.Immunol. 2010, 184:3978-3987.
43. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
44. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
45. Huang J.T., Welch J.S., Ricote M., Binder C.J., Willson T.M., Kelly C., Witztum J.L., Funk C.D., Conrad D., Glass C.K. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999, 400:378-382.
46. Hudson B.D., Shimpukade B., Mackenzie A.E., Butcher A.J., Pediani J.D., Christiansen E., Heathcote H., Tobin A.B., Ulven T., Milligan G. The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Mol. Pharmacol. 2013, 84:710-725.
47. Hundal R.S., Petersen K.F., Mayerson A.B., Randhawa P.S., Inzucchi S., Shoelson S.E., Shulman G.I. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J.Clin. Invest. 2002, 109:1321-1326.
48. Ilan Y., Maron R., Tukpah A.-M., Maioli T.U., Murugaiyan G., Yang K., Wu H.Y., Weiner H.L. Induction of regulatory Tcells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc. Natl. Acad. Sci. USA 2010, 107:9765-9770.
49. Johnson A.M.F., Olefsky J.M. The origins and drivers of insulin resistance. Cell 2013, 152:673-684.
50. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., Ohtsuka-Kowatari N., Kumagai K., Sakamoto K., Kobayashi M., et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J.Biol. Chem. 2006, 281:26602-26614.
51. Kang K., Reilly S.M., Karabacak V., Gangl M.R., Fitzgerald K., Hatano B., Lee C.-H. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab. 2008, 7:485-495.
52. Kawazoe Y., Naka T., Fujimoto M., Kohzaki H., Morita Y., Narazaki M., Okumura K., Saitoh H., Nakagawa R., Uchiyama Y., et al. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J.Exp. Med. 2001, 193:263-269.
53. Kim C.-S., Park H.-S., Kawada T., Kim J.-H., Lim D., Hubbard N.E., Kwon B.-S., Erickson K.L., Yu R. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int. J. Obes. (Lond.) 2006, 30:1347-1355.
54. Lanthier N., Molendi-Coste O., Cani P.D., van Rooijen N., Horsmans Y., Leclercq I.A. Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. FASEB J. 2011, 25:4301-4311.
55. Larsen C.M., Faulenbach M., Vaag A., Vølund A., Ehses J.A., Seifert B., Mandrup-Poulsen T., Donath M.Y. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N.Engl. J. Med. 2007, 356:1517-1526.
56. Lee J., Ozcan U. Unfolded protein response signaling and metabolic diseases. J.Biol. Chem. 2014, 289:1203-1211.
57. 2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity. Cell 2014, 157:1339-1352.
58. Li P., Lu M., Nguyen M.T.A., Bae E.J., Chapman J., Feng D., Hawkins M., Pessin J.E., Sears D.D., Nguyen A.-K., et al. Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J.Biol. Chem. 2010, 285:15333-15345.
59. Liu J., Divoux A., Sun J., Zhang J., Clément K., Glickman J.N., Sukhova G.K., Wolters P.J., Du J., Gorgun C.Z., et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 2009, 15:940-945.
60. Lumeng C.N., Deyoung S.M., Bodzin J.L., Saltiel A.R. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007, 56:16-23.
61. Lumeng C.N., DelProposto J.B., Westcott D.J., Saltiel A.R. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008, 57:3239-3246.
62. Mansuy-Aubert V., Zhou Q.L., Xie X., Gong Z., Huang J.-Y., Khan A.R., Aubert G., Candelaria K., Thomas S., Shin D.-J., et al. Imbalance between neutrophil elastase and its inhibitor α1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure. Cell Metab. 2013, 17:534-548.
63. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab. 2013, 17:851-859.
64. Molofsky A.B., Nussbaum J.C., Liang H.-E., Van Dyken S.J., Cheng L.E., Mohapatra A., Chawla A., Locksley R.M. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J.Exp. Med. 2013, 210:535-549.
65. Morris D.L., Cho K.W., Delproposto J.L., Oatmen K.E., Geletka L.M., Martinez-Santibanez G., Singer K., Lumeng C.N. Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ Tcells in mice. Diabetes 2013, 62:2762-2772.
66. Mothe-Satney I., Filloux C., Amghar H., Pons C., Bourlier V., Galitzky J., Grimaldi P.A., Féral C.C., Bouloumié A., Van Obberghen E., Neels J.G. Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice. Diabetes 2012, 61:2311-2319.
67. Murray P.J., Allen J.E., Biswas S., Fisher E.A., Gilroy D.W., Goerdt S., Gordon S., Hamilton J.A., Ivashkiv L.B., Lawrence T., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014, 41:14-20. this issue.
68. Neyrinck A.M., Cani P.D., Dewulf E.M., De Backer F., Bindels L.B., Delzenne N.M. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. Biochem. Biophys. Res. Commun. 2009, 385:351-356.
69. Nguyen M.T.A., Favelyukis S., Nguyen A.-K., Reichart D., Scott P.A., Jenn A., Liu-Bryan R., Glass C.K., Neels J.G., Olefsky J.M. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J.Biol. Chem. 2007, 282:35279-35292.
70. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., Otsu M., Hara K., Ueki K., Sugiura S., et al. CD8+ effector Tcells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15:914-920.
71. Nussbaum J.C., Van Dyken S.J., von Moltke J., Cheng L.E., Mohapatra A., Molofsky A.B., Thornton E.E., Krummel M.F., Chawla A., Liang H.E., Locksley R.M. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 2013, 502:245-248.
72. Obstfeld A.E., Sugaru E., Thearle M., Francisco A.-M., Gayet C., Ginsberg H.N., Ables E.V., Ferrante A.W. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes 2010, 59:916-925.
73. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., Red Eagle A., Vats D., Brombacher F., Ferrante A.W., Chawla A. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120.
74. Odegaard J.I., Ricardo-Gonzalez R.R., Red Eagle A., Vats D., Morel C.R., Goforth M.H., Subramanian V., Mukundan L., Ferrante A.W., Chawla A. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 2008, 7:496-507.
75. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., Li P., Lu W.J., Watkins S.M., Olefsky J.M. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
76. Oh D.Y., Morinaga H., Talukdar S., Bae E.J., Olefsky J.M. Increased macrophage migration into adipose tissue in obese mice. Diabetes 2012, 61:346-354.
77. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 2010, 72:219-246.
78. Orr J.S., Puglisi M.J., Ellacott K.L.J., Lumeng C.N., Wasserman D.H., Hasty A.H. Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. Diabetes 2012, 61:2718-2727.
79. Osborn O., Olefsky J.M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 2012, 18:363-374.
80. Ozcan U., Cao Q., Yilmaz E., Lee A.-H., Iwakoshi N.N., Ozdelen E., Tuncman G., Görgün C., Glimcher L.H., Hotamisligil G.S. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306:457-461.
81. Ozes O.N., Akca H., Mayo L.D., Gustin J.A., Maehama T., Dixon J.E., Donner D.B. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl. Acad. Sci. USA 2001, 98:4640-4645.
82. Patsouris D., Li P.-P., Thapar D., Chapman J., Olefsky J.M., Neels J.G. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 2008, 8:301-309.
83. Quiat D., Olson E.N. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J.Clin. Invest. 2013, 123:11-18.
84. Randolph G.J. Emigration of monocyte-derived cells to lymph nodesduring resolution of inflammation and its failure in atherosclerosis. Curr. Opin. Lipidol. 2008, 19:462-468.
85. Recalcati S., Locati M., Gammella E., Invernizzi P., Cairo G. Iron levels in polarized macrophages: regulation of immunity and autoimmunity. Autoimmun. Rev. 2012, 11:883-889.
86. Ruan H., Hacohen N., Golub T.R., Van Parijs L., Lodish H.F. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 2002, 51:1319-1336.
87. Saberi M., Woods N.-B., de Luca C., Schenk S., Lu J.C., Bandyopadhyay G., Verma I.M., Olefsky J.M. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab. 2009, 10:419-429.
88. Sabio G., Das M., Mora A., Zhang Z., Jun J.Y., Ko H.J., Barrett T., Kim J.K., Davis R.J. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 2008, 322:1539-1543.
89. Samuel V.T., Shulman G.I. Mechanisms for insulin resistance: common threads and missing links. Cell 2012, 148:852-871.
90. Sartipy P., Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 2003, 100:7265-7270.
91. Schmidt A.M., Moore K.J. The Semaphorin 3E/PlexinD1 axis regulates macrophage inflammation in obesity. Cell Metab. 2013, 18:461-462.
92. Schubert K.M., Scheid M.P., Duronio V. Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J.Biol. Chem. 2000, 275:13330-13335.
93. Shimizu I., Yoshida Y., Moriya J., Nojima A., Uemura A., Kobayashi Y., Minamino T. Semaphorin3E-induced inflammation contributes to insulin resistance in dietary obesity. Cell Metab. 2013, 18:491-504.
94. Solinas G., Karin M. JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction. FASEB J. 2010, 24:2596-2611.
95. Solinas G., Vilcu C., Neels J.G., Bandyopadhyay G.K., Luo J.-L., Naugler W., Grivennikov S., Wynshaw-Boris A., Scadeng M., Olefsky J.M., Karin M. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 2007, 6:386-397.
96. Solomon D.H., Massarotti E., Garg R., Liu J., Canning C., Schneeweiss S. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA 2011, 305:2525-2531.
97. Spite M., Hellmann J., Tang Y., Mathis S.P., Kosuri M., Bhatnagar A., Jala V.R., Haribabu B. Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity. J.Immunol. 2011, 187:1942-1949.
98. Stephens J.M., Pekala P.H. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J.Biol. Chem. 1991, 266:21839-21845.
99. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
100. Stienstra R., van Diepen J.A., Tack C.J., Zaki M.H., van de Veerdonk F.L., Perera D., Neale G.A., Hooiveld G.J., Hijmans A., Vroegrijk I., et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 2011, 108:15324-15329.
101. Stienstra R., Tack C.J., Kanneganti T.-D., Joosten L.A.B., Netea M.G. The inflammasome puts obesity in the danger zone. Cell Metab. 2012, 15:10-18.
102. Sullivan T.J., Miao Z., Zhao B.N., Ertl L.S., Wang Y., Krasinski A., Walters M.J., Powers J.P., Dairaghi D.J., Baumgart T., et al. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes. Metabolism 2013, 62:1623-1632.
103. Talukdar S., Oh Y., Bandyopadhyay G., Li D., Xu J., McNelis J., Lu M., Li P., Yan Q., Zhu Y., et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat. Med. 2012, 18:1407-1412.
104. Tam C.S., Sparks L.M., Johannsen D.L., Covington J.D., Church T.S., Ravussin E. Low macrophage accumulation in skeletal muscle of obese type 2 diabetics and elderly subjects. Obesity (Silver Spring) 2012, 20:1530-1533.
105. Tamura Y., Sugimoto M., Murayama T., Minami M., Nishikaze Y., Ariyasu H., Akamizu T., Kita T., Yokode M., Arai H. C-C chemokine receptor 2 inhibitor improves diet-induced development of insulin resistance and hepatic steatosis in mice. J.Atheroscler. Thromb. 2010, 17:219-228.
106. Tang T., Sui Y., Lian M., Li Z., Hua J. Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death. PLoS ONE 2013, 8:e81949.
107. Ueki K., Kondo T., Kahn C.R. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol. Cell. Biol. 2004, 24:5434-5446.
108. Urano F., Wang X., Bertolotti A., Zhang Y., Chung P., Harding H.P., Ron D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000, 287:664-666.
109. Ussher J.R., Koves T.R., Cadete V.J.J., Zhang L., Jaswal J.S., Swyrd S.J., Lopaschuk D.G., Proctor S.D., Keung W., Muoio D.M., Lopaschuk G.D. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 2010, 59:2453-2464.
110. Vallerie S.N., Furuhashi M., Fucho R., Hotamisligil G.S. A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity. PLoS ONE 2008, 3:e3151.
111. van Asseldonk E.J.P., Stienstra R., Koenen T.B., Joosten L.A.B., Netea M.G., Tack C.J. Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study. J.Clin. Endocrinol. Metab. 2011, 96:2119-2126.
112. *3-Leiden mice. J.Lipid Res. 2011, 52:942-950.
113. van Gils J.M., Derby M.C., Fernandes L.R., Ramkhelawon B., Ray T.D., Rayner K.J., Parathath S., Distel E., Feig J.L., Alvarez-Leite J.I., et al. The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat. Immunol. 2012, 13:136-143.
114. Vandanmagsar B., Youm Y.-H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., Ravussin E., Stephens J.M., Dixit V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011, 17:179-188.
115. Wan W., Lionakis M.S., Liu Q., Roffê E., Murphy P.M. Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice. Cardiovasc. Res. 2013, 97:580-588.
116. Wanschel A., Seibert T., Hewing B., Ramkhelawon B., Ray T.D., van Gils J.M., Rayner K.J., Feig J.E., O'Brien E.R., Fisher E.A., Moore K.J. Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention. Arterioscler. Thromb. Vasc. Biol. 2013, 33:886-893.
117. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J.Clin. Invest. 2003, 112:1796-1808.
118. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., Charo I., Leibel R.L., Ferrante A.W. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J.Clin. Invest. 2006, 116:115-124.
119. Williamson R.T. On the treatment of glycosuria and diabetes mellitus with sodium salicylate. BMJ 1901, 1:760-762.
120. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., Dorfman R., Wang Y., Zielenski J., Mastronardi F., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 2009, 15:921-929.
121. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., Tsui H., Wu P., Davidson M.G., Alonso M.N., et al. B cells promote insulin resistance through modulation of Tcells and production of pathogenic IgG antibodies. Nat. Med. 2011, 17:610-617.
122. Wu D., Molofsky A.B., Liang H.-E., Ricardo-Gonzalez R.R., Jouihan H.A., Bando J.K., Chawla A., Locksley R.M. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332:243-247.
123. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J.Clin. Invest. 2003, 112:1821-1830.
124. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001, 7:941-946.
125. Yang H., Youm Y.-H., Vandanmagsar B., Ravussin A., Gimble J.M., Greenway F., Stephens J.M., Mynatt R.L., Dixit V.D. Obesity increases the production of proinflammatory mediators from adipose tissue Tcells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J.Immunol. 2010, 185:1836-1845.
126. Zhang X., Xu A., Chung S.K., Cresser J.H.B., Sweeney G., Wong R.L.C., Lin A., Lam K.S.L. Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice. Diabetes 2011, 60:486-495.
127. Zhong J., Rao X., Braunstein Z., Taylor A., Narula V., Hazey J., Mikami D., Needleman B., Rutsky J., Sun Q., et al. T cell costimulation protects obesity-induced adipose inflammation and insulin resistance. Diabetes 2014, 63:1289-1302.